SITAGLIPTIN GLENMARK 100 MG TBL FLM 28
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 805,81 Kč. Maximální cena: 1 048,56 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Monohydrát sitagliptin-hydrochloridu (113,376 mg), sitagliptin (100 mg), hydrogenfosforečnan vápenatý, mikrokrystalická celulosa, sodná sůl kroskarmelosy, natrium-stearyl-fumarát, magnesium-stearát, polyvinylalkohol, ox… |
| Dostupnost / výpadek | The latest report from the manufacturer is from 29. 9. 2022. Výroba je oficiálně zahájena od 29. 9. 2022. |
| Kód SÚKL | 0248613 |
What is the maximum co-payment for SITAGLIPTIN GLENMARK?
If the insurance company contributes, the maximum co-payment is 805,81 Kč. The maximum pharmacy price is 1 048,56 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does SITAGLIPTIN GLENMARK have a counted co-payment set?
No, this medicine has no counted co-payment.
How much does the insurance company pay for one dispensed reimbursed pack?
242,75 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe SITAGLIPTIN GLENMARK?
Prescription is not conditional on a medical specialization.
What is the composition of SITAGLIPTIN GLENMARK?
Monohydrát sitagliptin-hydrochloridu (113,376 mg), sitagliptin (100 mg), hydrogenfosforečnan vápenatý, mikrokrystalická celulosa, sodná sůl kroskarmelosy, natrium-stearyl-fumarát, magnesium-stearát, polyvinylalkohol, oxid titaničitý, makrogol 3350, ointmentek, červený oxid železitý, žlutý oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to SITAGLIPTIN GLENMARK?
The medicine belongs to ATC group A10BH01 – . Medicines with the same active substance can be found here.
Who manufactures SITAGLIPTIN GLENMARK?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 29. 9. 2022. Production has been officially started as of 29. 9. 2022.
What is the unique code for SITAGLIPTIN GLENMARK?
The medicine has code 0248613. Code details can be found here.
How many packs of SITAGLIPTIN GLENMARK were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of SITAGLIPTIN GLENMARK were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026